Inflammatory lipids as a target for therapy in the rheumatic diseases

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.17, Iss.8, 2008-08, pp. : 1213-1224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Excess Cardiovascular Risk in Inflammatory Rheumatic Diseases: Pathophysiology and Targeted Therapy

Current Pharmaceutical Design, Vol. 18, Iss. 11, 2012-04 ,pp. : 1465-1477

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics, Target Molecules, and Biological Anti-Rheumatic Drugs in Autoimmune/Chronic Inflammatory Rheumatic Diseases

Current Pharmacogenomics, Vol. 4, Iss. 2, 2006-06 ,pp. : 105-111

Bentham Science Publishers

Access to resources Recommend Favorite

The Evolving Therapy of Rheumatic Diseases, The Future is Now

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 2, Iss. 1, 2002-04 ,pp. : 1-11

Bentham Science Publishers

Access to resources Recommend Favorite

The Relationship between Inflammatory and Oxidative Stress Biomarkers, Atherosclerosis and Rheumatic Diseases

Current Pharmaceutical Design, Vol. 20, Iss. 4, 2014-02 ,pp. : 585-600

Bentham Science Publishers

Access to resources Recommend Favorite

NF-&kgr;B: a therapeutic target in inflammatory diseases

By Curran C.L. Blackwell T.S. Christman J.W.

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 2, 2001-04 ,pp. : 197-204

Informa Healthcare

Access to resources Recommend Favorite